{"id":7921,"date":"2026-04-03T10:17:02","date_gmt":"2026-04-03T10:17:02","guid":{"rendered":"https:\/\/busondakika.com.tr\/?p=7921"},"modified":"2026-04-03T10:17:03","modified_gmt":"2026-04-03T10:17:03","slug":"kanserli-hucre-fotokopi-makinesi-gibi-calisiyor","status":"publish","type":"post","link":"https:\/\/busondakika.com.tr\/?p=7921","title":{"rendered":"Kanserli h\u00fccre fotokopi makinesi gibi \u00e7al\u0131\u015f\u0131yor"},"content":{"rendered":"<p> <strong>Kanser s\u00f6z konusu oldu\u011funda ak\u0131llarda soru i\u015faretleri ve kayg\u0131 artabiliyor ancak hastal\u0131\u011f\u0131n i\u015fleyi\u015fini ve tedavinin mant\u0131\u011f\u0131n\u0131 bilmek tabloyu daha net hale getiriyor. 1\u20137 Nisan Ulusal Kanser Haftas\u0131\u2019nda normal h\u00fccre ile kanserli h\u00fccre aras\u0131ndaki farklara de\u011finen Anadolu Sa\u011fl\u0131k Merkezi Hastanesi T\u0131bbi Onkoloji ve Hematoloji Uzman\u0131, Onkolojik Bilimler Koordinat\u00f6r\u00fc Prof. Dr. Necdet \u00dcskent, \u201cSinyal gelmedi\u011fi s\u00fcrece \u00e7o\u011falmayan normal h\u00fccrelere kar\u015f\u0131 kanser h\u00fccresi, \u00e7o\u011falmay\u0131 fotokopi makinesi gibi ger\u00e7ekle\u015ftiriyor. Kanser tedavisinin ba\u015far\u0131 oranlar\u0131n\u0131 art\u0131ran ak\u0131ll\u0131 ila\u00e7lar da bu durmak bilmeyen h\u00fccrelere \u2018art\u0131k intihar etmelisin\u2019 mesaj\u0131 veriyor\u201d a\u00e7\u0131klamas\u0131nda bulundu.<\/strong><\/p>\n<p>Yara iyile\u015fmesi s\u0131ras\u0131nda h\u00fccreler \u00e7o\u011falarak dokuyu onar\u0131r ve s\u00fcre\u00e7 tamamland\u0131\u011f\u0131nda bu \u00e7o\u011falma durur. Ancak kanserli h\u00fccrede bu programl\u0131 h\u00fccre \u00f6l\u00fcm\u00fcn\u00fcn olmad\u0131\u011f\u0131n\u0131 dile getiren Anadolu Sa\u011fl\u0131k Merkezi Hastanesi T\u0131bbi Onkoloji ve Hematoloji Uzman\u0131, Onkolojik Bilimler Koordinat\u00f6r\u00fc Prof. Dr. Necdet \u00dcskent, \u201cYeni geli\u015ftirilen ila\u00e7lar bu program\u0131 yeniden hat\u0131rlatma prensibiyle \u00e7al\u0131\u015f\u0131yor. Baz\u0131 ak\u0131ll\u0131 ila\u00e7lar do\u011frudan h\u00fccreye de\u011fil, \u00e7evresindeki onu besleyen damarlar\u0131 hedef al\u0131yor ve bu sayede a\u00e7 b\u0131rak\u0131lan kanser h\u00fccresi yok oluyor. Ak\u0131ll\u0131 ila\u00e7lar\u0131n fark yaratt\u0131\u011f\u0131 en \u00f6nemli nokta ise do\u011frudan hedefe y\u00f6nelerek yaln\u0131zca t\u00fcm\u00f6r\u00fc etkilemesi ve b\u00f6ylece sa\u011fl\u0131kl\u0131 h\u00fccreleri korumas\u0131. Geleneksel kemoterapide ise sa\u00e7, t\u0131rnak ve kemik ili\u011fi gibi \u00e7o\u011falmas\u0131 gereken h\u00fccreler de tedaviden olumsuz etkileniyor\u201d dedi.<\/p>\n<p><strong>\u00dclkeler aras\u0131 genetik farkl\u0131l\u0131klar ba\u015far\u0131 oran\u0131n\u0131 y\u00fczde 30\u2019a kadar \u00e7\u0131karabiliyor<\/strong><\/p>\n<p>Ak\u0131ll\u0131 ila\u00e7lar\u0131n kemoterapiye k\u0131yasla daha d\u00fc\u015f\u00fck yan etki g\u00f6sterdi\u011fini de vurgulayan \u00dcskent, \u201cAmeliyat ve kemoterapi gereksinimini azaltabilen ak\u0131ll\u0131 ila\u00e7lardan, akci\u011fer kanserlerinin yakla\u015f\u0131k y\u00fczde 10 ila 15\u2019inde fayda sa\u011flanabiliyor. Bu oran genetik farkl\u0131l\u0131klar nedeniyle Filipin, \u00c7in ve Japonya gibi \u00fclkelerde y\u00fczde 25-30 seviyelerine \u00e7\u0131kabiliyor. \u00d6zellikle hi\u00e7 sigara kullanmam\u0131\u015f kad\u0131n hastalarda ba\u015far\u0131 oran\u0131 y\u00fczde 50-60\u2019lara ula\u015f\u0131labiliyor. Ak\u0131ll\u0131 ila\u00e7 tedavisi i\u00e7in erken evre \u015fart\u0131 oldu\u011fu d\u00fc\u015f\u00fcn\u00fclse de asl\u0131nda bu tedaviyi kanserin yay\u0131l\u0131m g\u00f6sterdi\u011fi durumlarda daha s\u0131k tercih ediyoruz\u201d dedi.<\/p>\n<p><strong>Pankreas kanserinin y\u00fczde 80\u2019inde g\u00f6r\u00fclen mutasyona y\u00f6nelik yeni ila\u00e7lar geli\u015ftiriliyor<\/strong><\/p>\n<p>Ak\u0131ll\u0131 ila\u00e7lar\u0131n yeni bir geli\u015fme olarak g\u00f6r\u00fclse de ge\u00e7mi\u015finin 2000\u2019li y\u0131llar\u0131n ba\u015f\u0131na dayand\u0131\u011f\u0131n\u0131 a\u00e7\u0131klayan \u00dcskent, \u201c2003\u2019lerde l\u00f6semide sadece transplantasyon ile \u00f6m\u00fcr uzat\u0131labilirken hastal\u0131\u011fa neden olan yap\u0131sal bozukluk tespit edildi ve buna y\u00f6nelik geli\u015ftirilen tedaviyle hastalar tamamen iyile\u015fti. Kan kanserinde ya\u015fanan geli\u015fme ak\u0131ll\u0131 ila\u00e7lar\u0131n temelini olu\u015fturdu. Daha sonra bu yakla\u015f\u0131m di\u011fer kanser t\u00fcrlerine de ta\u015f\u0131nd\u0131 ve 2007\u2019de akci\u011fer kanserinde EGFR mutasyonuna kar\u015f\u0131 geli\u015ftirilen tablet ila\u00e7la kemoterapiye gerek kalmadan t\u00fcm\u00f6rlerde gerileme g\u00f6r\u00fcld\u00fc. Ak\u0131ll\u0131\u00a0ila\u00e7 tedavisinin uygunlu\u011fu kanser t\u00fcr\u00fcne de\u011fil mutasyonun t\u00fcr\u00fcne g\u00f6re belirlenir. Uygun hastalarda bu ila\u00e7lar t\u00fcm\u00f6r\u00fc tamamen yok edebilir ve ameliyata gerek kalmayabilir. Ayn\u0131 mutasyon g\u00f6r\u00fcld\u00fc\u011f\u00fcnde t\u00fcm\u00f6r hangi organda olursa olsun benzer ba\u015far\u0131 elde edilir ve hastan\u0131n bu tedavilere uygun olup olmad\u0131\u011f\u0131 k\u0131sa s\u00fcrede sonu\u00e7lanan genetik testlerle anla\u015f\u0131labilir. Bug\u00fcn t\u00fcm mutasyonlara kar\u015f\u0131 ila\u00e7 bulunmu\u015f olmasa da \u00e7al\u0131\u015fmalar h\u0131zla s\u00fcr\u00fcyor. \u00d6rne\u011fin pankreas kanserinin y\u00fczde 80\u2019inde g\u00f6r\u00fclen bir mutasyona y\u00f6nelik yeni ila\u00e7lar \u00fczerinde \u00e7al\u0131\u015f\u0131l\u0131yor\u201d dedi.<\/p>\n<p>\u00a0<\/p>\n<p>Kaynak: (BYZHA) Beyaz Haber Ajans\u0131<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Kanser s\u00f6z konusu oldu\u011funda ak\u0131llarda soru i\u015faretleri ve kayg\u0131 artabiliyor ancak hastal\u0131\u011f\u0131n i\u015fleyi\u015fini ve tedavinin mant\u0131\u011f\u0131n\u0131 bilmek tabloyu daha net hale getiriyor.<\/p>\n","protected":false},"author":1,"featured_media":7922,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[23],"tags":[],"class_list":["post-7921","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik"],"_links":{"self":[{"href":"https:\/\/busondakika.com.tr\/index.php?rest_route=\/wp\/v2\/posts\/7921","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/busondakika.com.tr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/busondakika.com.tr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/busondakika.com.tr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/busondakika.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=7921"}],"version-history":[{"count":1,"href":"https:\/\/busondakika.com.tr\/index.php?rest_route=\/wp\/v2\/posts\/7921\/revisions"}],"predecessor-version":[{"id":7923,"href":"https:\/\/busondakika.com.tr\/index.php?rest_route=\/wp\/v2\/posts\/7921\/revisions\/7923"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/busondakika.com.tr\/index.php?rest_route=\/wp\/v2\/media\/7922"}],"wp:attachment":[{"href":"https:\/\/busondakika.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=7921"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/busondakika.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=7921"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/busondakika.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=7921"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}